robert henric

robert henric

Followers 18
Following 19
The study involved four major activities in estimating the current size of the breast reconstruction market.Exhaustive secondary research was conducted to collect information on the market and its different sub-segments.The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.Then, both top-down and bottom-up approaches were employed to estimate the complete market size.After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.Secondary Research;The secondary sources referred to for this research study on the breast reconstruction market include publications from government sources such as white papers; articles from recognized authors; gold standard and silver standard websites, directories, and databases; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations.Browse 138 market data Tables and 29 Figures spread through 136 Pages and in-depth TOC on “Breast Reconstruction Market”Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=186501593Expected Revenue Surge: The global breast reconstruction market size is expected to grow from USD 603 million by 2025 from USD 430 million in 2020, at a CAGR of 7.0%.Geographical Scenario in Depth: The breast reconstruction market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World.In 2019, North America held the largest share of the market, followed by Europe.
1
The regenerative medicine market estimating the current size and exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.Both top-down and bottom-up approaches were employed to estimate the complete market size.After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and sub-segments.According MarketsandMarkets™ Research – The report “Regenerative Medicine Market by Product (Cell Therapies (Autologous, Allogenic), Stemcell Therapy, Tissue-engineering, Gene Therapy), Application (Wound Care, Musculoskeletal, Oncology, Dental, Ocular), Geography – Global Forecast to 2025″, is projected to reach USD 17.9 billion by 2025 from USD 8.5 billion in 2020, at a CAGR of 15.9%.COVID-19 Impact on Global Regenerative medicine market;COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus.The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020.Due to nationwide lockdowns, denied wound care services, cancelled or postponed elective surgeries, and increasing skin injuries in COVID-19 medical care providers, the regenerative medicine market is expected to register a certain decline during the forecast period.
1 1
They are also used in research laboratories and pharmaceutical & biotechnology companies, where human cells are handled and maintained for the purpose of R The growth of this market is primarily driven by the presence of stringent regulations governing their application and usage.Technological advancements in disinfectant types and techniques have also ensured their overall demand among end users.According MarketsandMarkets™ Research – The report “Surface Disinfectant Market by Composition (Quaternary Ammonium, Alcohols, Chlorine, Hydrogen Peroxide), Type (Liquids, Sprays, Wipes), Application (Surface, Instrument), End User (Hospitals, Diagnostic and Research Labs) – Global Forecast to 2025″, is projected to reach USD 3.6 billion by 2025 from USD 3.1 billion in 2020, at a CAGR of 3.0% from 2020 to 2025.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=231286043Growth Driver: High prevalence of HAIs;Hospital-acquired infections (HAIs) are nosocomial infections that occur during a patient’s stay at hospitals and related facilities and are not observed at the time of admission.These infections include central line-associated bloodstream infections, surgical site infections, catheter-associated urinary tract infections, hospital-acquired pneumonia, ventilator-associated pneumonia, and Clostridium difficile infections.The incidence of HAIs is mainly dependent on the patient’s immune status, infection control practices, and the prevalence of various infectious agents around the healthcare facility.Due to the direct correlation between the geriatric population, occurrence of chronic diseases, increase in the hospitalization rates, and an increase in the risk of spread of HAIs, growth in this population segment will bolster the demand for surface disinfectants.Opportunity: Growing healthcare industry in emerging economies;Emerging economies such as India, Brazil, China, and South Africa provide significant opportunities for players in the surface disinfectants market.According to the IMF, in 2016, these emerging economies accounted for more than 60% of the global GDP.
1
The Global Metabolomics Market research study involved extensive use of secondary sources, directories, and databases to identify and collect information and in-depth interviews were conducted with various primary respondents, including key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information, and to assess market prospects.According MarketsandMarkets™ Research – The report “Metabolomics Market by Product (GC,UPLC, CE, Surface based Mass Analysis), Application (Biomarker Discovery, Drug Discovery,Functional Genomics), Indication (Cardiology, Oncology,Inborn Errors), End User (Academic Institute,CROs) – Global Forecast to 2025” The global metabolomics technology market size is projected to reach USD 4.1 billion by 2025, at a CAGR of 13.4% between 2020 and 2025The major factors driving the growth of this market are the growing R expenditure in the pharmaceutical & biopharmaceutical industry, growing demand for personalized medicine and increasing use of metabolomics in toxicology testing are driving the growth of the global metabolomics industry.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=900Growth Driver: Availability of government and private funding for metabolomics research;Metabolomic studies are gaining prominence in the life science industry as they help reveal the optimum level of specific metabolites associated with the onset/progression of a disease and the exposure or response to treatment.As metabolomics is considered a novel approach with tremendous potential, additional research is being conducted in this field.Also, in recent years, the focus on metabolomic biomarkers has increased in drug development.As a result of these factors, government and private investments in metabolomics research is increasing.According to a report by The Metabolomics Innovation Centre (TMIC), metabolomics has experienced tremendous growth since the last decade.High-impact metabolomic discoveries in several diseases, such as cancer, have increased investments in metabolomics facilities across the globe.Opportunity:Biomarker development;Metabolomics is used to identify new biomarkers through bioinformatics tools, which indicate the changes in the physiological state of a cell or tissue.As a result of these technological developments, new biomarkers are being regularly discovered.
The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.According MarketsandMarkets™ Research – The report “Depth Filtration Market by Media Type (Cellulose, Activated Carbon), Product (Capsule, Sheet, Module), Application(Final Product Processing (Biologics), cell Clarification, Viral Clearance, Operation Scale (Manufacturing, Lab) – Global Forecast to 2025”, is estimated to grow from USD 1.7 billion in 2019 to USD 2.9 billion by 2025, at a CAGR of 9.0% during the forecast period.The growth of Depth Filtration Market is majorly driven by factors such as the growing adoption of disposable filters and benefits such as ease of use and low cost of media and filters.However, factors such as the requirement of high capital investments for setting up production facilities are expected to restrain the growth of this market during the forecast period.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=143876285Geographical View in-detailed:Segmented into four major regions, namely, North America, Europe, the Asia Pacific, Latin America, and Middle-East & Africa.In 2019, North America accounted for the largest share of 38.0% of the global depth filtration market, followed by Europe, with a share of 29.2%.The large share of the North American region can be attributed to a large number of pharmaceutical and biotechnology companies in the region and the presence of a well-established healthcare market.The Asia Pacific market, on the other hand, is expected to register the highest growth during the forecast period.Factors such as increasing research and development by pharmaceutical companies in China, India, and Japan are likely to support the growth of this market.Global Key Leaders:The major companies operating in the global depth filtration market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), GE Healthcare (US), 3M (US), Parker Hannifin Corporation (US), Porvair Filtration Group (UK), ErtelAlsop (US), Amazon Filters Ltd. (UK), Meissner Filtration Products, Inc. (US), Donaldson Comany, Inc. (US), Eaton Corporation (Ireland), Saint-Gobain Performance Plastics (France), Clariance Technique (Australia), Repligen Corporation (US), Microfilt India Pvt.
1
The study involved four major activities in estimating the current market size for pen needles.Exhaustive secondary research was done to collect information about the market, peer markets, and the parent market.The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research.Thirdly, both top-down and bottom-up approaches were employed to estimate the complete market size.According MarketsandMarkets™ Research – The report “Pen Needles Market by Type (Standard Pen Needles and Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) – Global Forecast to 2024“, is expected to reach USD 1.8 billion by 2024 from an estimated USD 1.1 billion in 2019, at a CAGR of 10.8% during the forecast period (2019–2024).The Growth in the pen needles market is mainly driven by factors such as the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries.The insulin therapy segment is expected to grow at a higher CAGR during the forecast period primarily due to the high and growing diabetic population globally.Since pen needles need to be replaced after every injection, the rising use of insulin pens is a major factor driving the demand for pen needles.
2
The study involved two major activities in estimating the current size of the Protein Crystallization and Crystallography Market.Exhaustive research was conducted to collect information on the market as well as its peer and parent markets.The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research.Revenue-based estimation approaches were employed to estimate the complete market size.According to the new market research report “Protein Crystallization and Crystallography Market by Technology (NMR, X-Ray Crystallography), Product & Service (Instrument (Liquid Handling (Automated)), Consumable (Reagent, Microplate) End User, and Region – Global Forecast to 2025” published by MarketsandMarkets™, the growth in this market is attributed to the increasing adoption of protein therapeutics, technological advancements in protein crystallization instruments and consumables, and the increasing focus on miniaturization.However, the high cost of instruments is expected to restrain the growth of this market during the forecast period.The Global Protein Crystallization and Crystallography Market size is projected to reach USD 1.7 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 8.9% during the forecast period.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=147057058Geographical Scenario in Depth:The protein crystallization market is divided into five major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW).The growth in this market can be attributed to the increasing investments in the development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, and rising focus of stakeholders on research projects involving proteins.Leading Key-Players:The major companies in the protein crystallization and crystallography market are Rigaku Corporation (Japan), Hampton Research (US), Jena Bioscience GmbH (Germany), and Bruker Corporation (US).Rigaku Corporation (Japan) is the leading player in the global protein crystallization market.
1
Viral inactivation testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics.The major drivers for the market are rapid growth in pharmaceutical and biotechnology industries and strong trend of R investments in life sciences industry.Increasing number of new drug launches, rise in chronic disease burden, and increasing government support for the pharmaceutical and biotechnology industries will also aid the growth of this market.According MarketsandMarkets™ Research – The report “Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) – Global Forecast”, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global market along with the estimates and forecasts of the revenue and market share analysis.The Global Viral Inactivation Market is expected to grow at a CAGR of 12.3% to reach USD 573.0 Million.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=121427017Market Segmentation in Depth:By method, divided into solvent detergent method, pasteurization, and other methods.Other viral inactivation method includes low pH, microwave heating, irradiation, and high-energy light.Of these, the solvent detergent method segment accounted for the largest share of the global viral inactivation market in 2015.The application segments included in this report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics.Of these the vaccines and therapeutics application hold the highest share.By end user, Segmented into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users.Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121427017Geographical View in-detailed:Segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW).
1
The study involved four major activities in estimating the current market size for infrared spectroscopy.The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.Impact of Covid-19 on the infrared and terahertz spectroscopy market;The COVID-19 outbreak has upended many lives and businesses on an unprecedented scale.The rising prevalence of coronavirus disease has driven the demand for accurate diagnosis and treatment devices in several countries across the globe.Companies are developing software that provides automatic measurement tools that perform elevated skin temperature screenings of individuals in two seconds or less at entries, checkpoints, and other high-traffic areas while maintaining recommended social distancing guidelines.Apart from infrared spectroscopy, researchers are also increasingly using terahertz spectroscopy as a potential tool for detecting the virus.Owing to these advantages the market has witnessed significant growth.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=248742550According MarketsandMarkets™ Research – The report “Infrared and Terahertz Spectroscopy Market by Instrument Type (Benchtop Instruments, Microscopy Instruments, Portable Instruments, Hyphenated Instruments), Spectrum, Application – Global Forecast to 2025” the infrared spectroscopy market is expected to reach USD 1.3 billion by 2025 from USD 1.0 billion in 2020, at a CAGR of 5.2% during the forecast period.Growth Drivers: Growing semiconductor industry;Terahertz spectroscopy is widely used for developing and testing semiconductor materials and for detecting faults in circuits.The ability to detect and quantify charge carriers is expected to create avenues for using the terahertz technology in semiconductors.
1
Major Growth Boosting Factors: The increasing prevalence of chronic diseases across the globe, increasing government and corporate investments in healthcare projects and infrastructure development, rising demand for infection control measures to curb the occurrence of HAIs, and the rising demand for medical devices are driving the growth of the global medical supplies market.Moreover, the rising medical tourism and emerging markets are expected to offer significant growth opportunities to players operating in the medical supplies industry in the coming years.Revenue Growth Opportunities: The Global Medical Supplies Market is projected to grow from USD 133.5 billion by 2025 from USD 132.6 billion in 2020, at a CAGR of 4.6%Recent Developments:# In 2020, Baxter launched peri-strips dry with secure grip technology for reliable staple line reinforcement in surgical procedures.# In 2020, Fresenius Medical Care AG & Co. KGaA inaugurated a EUR 30 million expansion of its transfusion and apheresis disposables plant in the Dominican Republic.The site also includes a large warehouse.# In 2019, Boston Scientific Corporation acquired BTG plc with a focus on offering best-in-class technologies, unparalleled clinical evidence, and strengthened commercial infrastructure.Market Size Estimation;Both top-down and bottom-up approaches were used to estimate and validate the total size of the medical supplies market.The research methodology used to estimate the market size includes the following:# The key players in the industry and market have been identified through extensive secondary research.# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=64344238Based on type;The medical supplies market is segmented into diagnostic supplies, infusion & injectable supplies, intubation & ventilation supplies, disinfectants, personal protective equipment, sterilization consumables, wound care consumables, dialysis consumables, radiology consumables, catheters, sleep apnea consumables, and other medical supplies.The intubation & ventilation consumables segment is expected to grow at the highest CAGR during the forecast period.This is attributed to the rising incidence of respiratory diseases, such as asthma and COPD, along with the increasing prevalence of COVID-19 across the globe.Based on application,The medical supplies market is segmented into urology, wound care, radiology, respiratory, infection control, cardiology, IVD, and other applications.
1
The study involved four major activities to estimate the current size of the Prefilled Syringes Market.The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.The Prefilled Syringes Market includes major Tier I and II suppliers like Becton, Dickinson and Company (US), Gerresheimer (Germany), SCHOTT AG (Germany), and West Pharmaceutical Services, Inc. (US), and Nipro Corporation (Japan).These suppliers have their manufacturing facilities spread across regions such as North America and Europe.COVID-19 has impacted their businesses as well.Routine care for chronic diseases is an ongoing challenge amidst the global COVID-19 pandemic due to the change in routine care to virtual communication.Diabetes, chronic obstructive pulmonary disease, and hypertension were the most impacted conditions due to a reduction in access to care.
2
The study involved four major activities in estimating the current market size for UV/visible spectroscopy.Exhaustive secondary research was done to collect information on the market and its different sub-segments.The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.Thereafter market breakdown and data triangulation was used to estimate the market size of segments and sub-segments.According MarketsandMarkets™ Research – The report “UV/Visible Spectroscopy Market by Instrument Type (Single-Beam, Dual-Beam), Application (Academic Application, Industrial Application), End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes) – Global Forecast to 2025“, is expected to reach USD 1.2 billion by 2025 from USD 1.0 billion in 2020, at a CAGR of 4.7%.The Growth in UV/visible Spectroscopy market is mainly driven by factors such as application of UV/visible spectroscopy in environmental screening, growing use of UV/visible spectroscopy in pharmaceutical & biotechnology industry, technological advancements and increasing need for food analysis.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=243898303Growth Drivers: Increasing application of UV/visible spectroscopy in pharmaceutical & biotechnology industry to drive market growthThe application of UV/visible spectroscopy as an analytical technique in pharmaceutical and biotechnology R is likely to grow due to technological advancements in spectroscopy systems that have enabled high throughput screening, microvolume sampling, and software integration with instruments.Such advancements have ensured that a large number of data points can be gathered, recorded, and shared using these systems, which proves highly beneficial for R and is a major factor driving the growth of UV/visible spectroscopy market.Opportunities: Growing opportunities in emerging nationsAs compared to mature markets such as the US and Europe, emerging markets such as China and India are expected to provide significant growth opportunities for players.Many key industry players are strengthening their presence worldwide by establishing new facilities, R, and innovation centers.Shimadzu Corporation set up a new research facility at the Technology Research Laboratory in Keihanna Science City, Japan.
1
The Research Study involved the extensive use of both primary and secondary sources.The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.According MarketsandMarkets™ Research – The report “Lancets Market by Type (Safety Lancets (Push button, Pressure Activated, Side Button), Personal Lancets), Application (Glucose Testing, Hemoglobin Testing), End User (Hospital, Clinic, Homecare), Region – Global Forecast to 2024″, the Lancing Devices & Lancets Market is projected to grow at a CAGR of 12.4% during the forecast period to reach USD 1,442 million by 2024 from USD 804 million in 2019.The Growth in the market is mainly driven by the growing prevalence of diabetes and the high prevalence of infectious diseases across the globe.In addition, emerging markets such as India and China are expected to offer growth opportunities for players operating in the lancets market during the forecast period.However, the risk of needlestick injuries, the reuse of lancets, and the poor reimbursement scenario in developing countries are restricting the growth of this market.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=86063487Safety Lancet is expected to be the most widely used type of the lancets.The safety lancets accounted for the largest market share in 2018.This is primarily be attributed to the advantages associated with safety lancets such as their ease of use, the capability to prevent needlestick injuries and cross-contamination, and painlessness of vein puncture.The growing prevalence of diabetes has resulted in the increased adoption of lancets to effectively handle the growing patient pool.Geographical View in-detailed:North America dominated the lancets market, followed by Europe.
2
The study involved four major activities in estimating the current market size for the lymphedema diagnostics market.The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.According MarketsandMarkets™ Research – The report “Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) – Global Forecasts to 2024“, is projected to reach USD 35 million by 2024 from USD 24 million in 2019, at a CAGR of 7.4%The growing global prevalence of lymphedema and cancer; technological advancements in diagnostic imaging modalities; and increasing investments, funds, and grants by public-private organizations are the major factors driving the growth of this market.However, the high cost of diagnostic imaging systems, the short half-life of radio-pharmaceuticals, the limited supply of helium, and the increasing adoption of refurbished diagnostic imaging systems are expected to restrain the growth of this marketRequest Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=145177203The lymphoscintigraphy segment accounted for the largest share of the lymphedema diagnostics market in 2018.Based on technology, segmented into lymphoscintigraphy, magnetic resonance imaging (MRI), ultrasound imaging, computed tomography (CT), X-ray lymphography, bioimpedance analysis, and near-infrared fluorescence imaging.In 2018, the lymphoscintigraphy segment accounted for the largest share of the market.The noninvasive nature and easy reproducibility of this technology, and the fact that lymphoscintigraphy does not adversely affect the lymphatic vascular endothelium are some of the key advantages supporting the adoption of this technology.The cancer segment accounted for the largest share of the lymphedema diagnostics therapy market in 2018.On the basis of disease type, segmented into cancer, inflammatory diseases, cardiovascular disease, and other diseases (congenital abnormalities, trauma-related conditions, infections, and filariasis).The large share of this segment can be attributed to the rising prevalence of cancer-associated lymphedema and increasing awareness about early disease diagnosis.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145177203Geographical View in-detailed:The lymphedema diagnostics therapy market is segmented into four regional segments, namely, North America, Europe, the Asia Pacific, and the Rest of the World.
2
Major Growth Boosting Factors: The growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population, and procedural benefits offered by bone stimulation devices in bone fracture treatments are some key factors propelling the growth of the Bone Growth Stimulator Market.However, limited medical reimbursement for bone stimulation products and high treatment costs associated with BMP and PRP products may hinder the growth of this market during the forecast period.Revenue Growth Opportunities: The Global Bone Growth Stimulator Market is estimated to reach USD 1.41 billion, at a CAGR of 5.4% during the forecast period.Procedural benefits offered by bone stimulation devices in bone fracture treatment;Bone growth stimulation devices offer a cost-effective and safer alternative mode to treat orthopedic diseases as compared to traditional surgical therapies for nonunion bone fractures.This is expected to aid the adoption of bone growth stimulation products among key end users.This is also augmented by clinical evidence that validates the clinical efficacy of bone growth stimulation products in the effective and rapid bone regeneration as compared to traditional methodologies.As of 2015, the average treatment cost saving for diabetes patients in the U.S. being treated with electrical bone growth stimulation (EBGS) devices was reported to be ~USD 4,800 and USD 3,000 as compared to non-stimulation based treatment and low-intensity pulsed Ultrasound stimulation (LIPUS) treatment, respectively (Source: Journal of Diabetes & Metabolism, 2013).Similarly, a research study was undertaken among adult patients diagnosed with a nonunion bone fracture between July 2006 and September 2009 in the U.S.This research study estimates the per patient healthcare expenditure for nonunion fractures treatment with EBGS devices to be USD 21,632 as compared to USD 23,843 and USD 23,964 for non-stimulation based treatment and LIPUS treatment, respectively (Source: Orthopedic Research and Reviews, 2013).
1
The research study involved four major activities in estimating the current size of the European Mammography Workstations Market.Exhaustive secondary research was carried out to collect information on the market, its peer markets, and the parent market.The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.Both top-down and bottom-up approaches were employed to estimate the complete market size.According MarketsandMarkets™ Research – The report “European Mammography Workstations Marketby Modality (Multimodal, Standalone), Application (Diagnosis, Advanced Imaging, Clinical Review), End User (Hospital, Breast Care Centers, Academia), Country (Germany, UK, France, Italy, Spain) – Forecast to 2024” the mammography workstations market is projected to reach USD 14 million by 2024 from USD 10 million in 2018, at a CAGR of 5.5% during the forecast period.Recent Developments in Mammography Workstations Market:# In February 2019, Fujifilm (Japan) launched ASPIRE Bellus II.# In January 2018, Agfa-Gevaert NV (Belgium) signed a contract with the West Suffolk NHS Foundation Trust (UK) in order to implement enterprise imaging for radiology platform.# In May 2017, Siemens AG (Germany) and Fraunhofer MEVIS (Germany) entered into a partnership for developing artificial intelligence software systems to facilitate diagnosis and therapy decisions in order to support physicians to define the best possible treatment approach.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=101392240The multimodality mammography workstations segment accounted for the largest share of the market.On the basis of modality, segmented into mammography (X-ray) workstations and multimodality mammography workstations.In 2018, the multimodality mammography workstations segment accounted for the larger share of the European mammography workstations market.This can be attributed to the increasingly supportive government initiatives/regulations in Europe, increasing awareness about the diagnostic efficacy of contrast-enhanced digital mammography, growing market availability of integrated mammography solutions, techno-commercial advantages associated with multimodality mammography workstations, and the rising prevalence of breast cancer.The breast care centers segment is expected to register the highest growth rate in the market.On the basis of end users, segmented into hospitals, surgical clinics, & diagnostic imaging centers; breast care centers; and researchers & academia.
1
The study involved four major activities in estimating the current size of the regenerative medicine market.Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.Both top-down and bottom-up approaches were employed to estimate the complete market size.Major Growth Boosting Factors: Growth in Regenerative Medicine Market is largely driven by the rising prevalence of chronic diseases, genetic disorders, and cancer; rising investments in regenerative medicine research; and the growing pipeline of regenerative medicine products.Revenue Growth Opportunities: The Global Regenerative Medicine Market is expected to reach USD 17.9 billion by 2025 from USD 8.5 billion in 2020, at a CAGR of 15.9%.Recent Developments:# In February 2020, Integra Lifesciences (US) launched AmnioExcel Plus Placental allograft membrane.# In November 2019, Stryker Corporation (US) acquired Wright Medical (US) to strengthen its product portfolio.# In March 2019, Smith & Nephew (UK) acquired Osiris Therapeutics (US) to strengthen its product portfolio.Growth Opportunity: Implementation of the 21st Century Cures Act;The 21st Century Cures Act was signed into law in the US in December 2016.Among other objectives, this new law has been enacted to advance regenerative medicine research and medical innovation and covers various provisions that may impact the development and approval of several products in the coming years.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=65442579Based on products,The regenerative medicine market is segmented into tissue-engineered products, cell therapies, gene therapies, and progenitor and stem cell therapies.The tissue-engineered products segment accounted for the largest share in the market in 2019.
1
According to the new market research report “Active Implantable Medical Devices Market by Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing Devices) – Global Forecast” published by MarketsandMarkets™.Revenue Growth Opportunities: The Active Implantable Medical Devices Market is estimated to grow at a CAGR of 7.8%, to reach USD 26.75 Billion, However, unfavorable healthcare reforms in the U.S., issues related to the use of implantable medical devices, and the high cost of implants may hinder the growth of this market to a certain extent.Lucrative opportunities in emerging markets and the development of subcutaneous implantable cardioverter defibrillators offer significant growth opportunities in this market.Increasing market consolidation and the development of innovative, easy-to-use implantable cardiovascular products with increased longevity are the major trends for this market.Growth Boosting Factors:# Increasing Burden of Cardiovascular Diseases# Rising Prevalence of Neurological Disorders# Investments and Funds to Develop Technologically Advanced Products# Expanded Applications of Neurostimulators# Favorable Reimbursement Scenario for Ent Procedures in Developed CountriesMarket Opportunities;# Emerging Markets Offer Significant Growth Opportunities# Development of Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=102063992Based on product;Segmented into implantable cardioverter defibrillators, implantable cardiac pacemakers, implantable heart monitors/insertable loop recorders, ventricular assist devices, neurostimulators, and implantable hearing devicesThe implantable cardioverter defibrillators segment accounted for the largest share of the global active implantable medical devices market.However, the implantable hearing devices segment is expected to witness the highest growth in the next five years.The growth of the implantable hearing devices is mainly attributed to the increasing prevalence of hearing loss across the globe and growing ENT procedures due to favorable reimbursement policies in the developed countries.Geographical Scenario: North America is the largest regional segment for the active implantable medical devices market.The large share of this regional segment can be attributed to the growth in geriatric population, increasing prevalence of cardiovascular and neurological diseases, high accessibility to advanced technologies, increasing development of innovative and technologically advanced products, and increasing healthcare expenditure in the region.However, the market in the Asia-Pacific region is expected to grow at the highest CAGR, owing to the growth in geriatric population, growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, growing demand for advanced technologies to develop advanced products, and less stringent regulations.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102063992Global Leaders: Medtronic plc (Ireland), Abbott Laboratories (U.S.), and Boston Scientific Corporation (U.S.) held the major share of the implantable cardiovascular and neurostimulators devices market.
1
According to the new market research report “Breath Analyzer Market by Technology (Fuel Cell, Semicoductor Oxide Sensor, Others), End User (Law Enforcement Agencies, Enterprises, Individuals ), Application, Region (North America, Europe, APAC, RoW) – Global Forecast to 2025“, published by MarketsandMarkets™, is expected to reach USD 1,167 million by 2025 from USD 524 million in 2020, at a CAGR of 17.4% during the forecast period.Impact of Covid-19 on the breath analyzer market;The COVID-19 outbreak has upended many lives and businesses on an unprecedented scale.The pandemic has caused significant disruptions to businesses and economic activities globally.Various governments worldwide have provided guidelines to postpone or delay non-essential medical and surgical procedures to reduce the strain on the healthcare system and decrease disease transmission.Restrictions and lockdowns were also imposed in the areas of travel, business operations, public gatherings, gaming or gambling venues, casinos, health clubs, fitness/wellness centers, and shelter-in-place orders, all of which have further impacted market growth.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=57484012The Growth in the breath analyzer market can primarily be attributed to factors such as alcohol and drug abuse, stringent government regulations and increasing use of breath analyzers in detecting various diseases.The fuel cell segment is expected to account for the largest share of the market in 2020Based on technology, the breath analyzers market is segmented into fuel cells, semiconductor oxide sensors, and other technologies (infrared spectroscopy and chemical crystals).Fuel cell-based breath analyzers offer an extremely high level of accuracy, sensitivity, and reliability.These analyzers are considered the gold standard of handheld alcohol testers for both personal and professional use.The alcohol detection segment is expected to account for the largest share of the market in 2020On the basis of application, the breath analyzers market is segmented into alcohol detection, drug abuse detection, and medical applications.
1
Major Growth Boosting Factors: The Continuous support in the form of investments and grants, and personalized medicine fueling the demand for personalized humanized rat models are some of the factors driving the growth of the rat model market.These rat model are being used in many applications such as toxicology, oncology, diabetes, neurology, immunology and infectious diseases, and others (rare disease, cardiovascular, metabolic disease, hematopoiesis, and regenerative medicines).Revenue Growth Opportunities: The overall Rat Model Market is expected to reach USD 588.9 million, at a CAGR of 8.7%Major Market Developments;# In August 2016, Charles River Laboratories, Inc. entered into a strategic partnership with The Milner Therapeutics Institute and Consortium (UK).This partnership with the Consortium allows the academic institutions access to Charles River’s early discovery and drug development and services for the early stage drug development processes.# In September, 2016, Charles River Laboratories International, Inc. acquired Agilux Laboratories (US), a provider of bioanalytical services, drug metabolism and pharmacokinetic services, and pharmacology services.This acquisition is expected to compliment Charles River’s non-clinical portfolio and improve the clients’ early-stage research efforts by enabling them to seamlessly transition their drug candidates through the discovery and safety assessment process.# In October 2015, Horizon Discovery Group plc expanded its UK based headquarters.The new facility is likely to accommodate 200 employees across manufacturing, services, research, and general and administrative functions.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=76036494On the basis of type,The rat model market is segmented into outbred rats, inbred rats, knockout/genetically engineered rats, hybrid/congenic rats, conditioned/surgically modified rats, and immunodeficient rats model.Knockout/genetically engineered rats segment is expected to grow at the highest CAGR during the forecast period.
1
More

Top